Home > National Drug Code (NDC) > Lisinopril and Hydrochlorothiazide

Lisinopril and Hydrochlorothiazide - 0615-7581-39 - (Lisinopril and Hydrochlorothiazide)

Alphabetical Index


Drug Information of Lisinopril and Hydrochlorothiazide

Product NDC: 0615-7581
Proprietary Name: Lisinopril and Hydrochlorothiazide
Non Proprietary Name: Lisinopril and Hydrochlorothiazide
Active Ingredient(s): 12.5; 10    mg/1; mg/1 & nbsp;   Lisinopril and Hydrochlorothiazide
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Lisinopril and Hydrochlorothiazide

Product NDC: 0615-7581
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075776
Marketing Category: ANDA
Start Marketing Date: 20110913

Package Information of Lisinopril and Hydrochlorothiazide

Package NDC: 0615-7581-39
Package Description: 30 TABLET in 1 BLISTER PACK (0615-7581-39)

NDC Information of Lisinopril and Hydrochlorothiazide

NDC Code 0615-7581-39
Proprietary Name Lisinopril and Hydrochlorothiazide
Package Description 30 TABLET in 1 BLISTER PACK (0615-7581-39)
Product NDC 0615-7581
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lisinopril and Hydrochlorothiazide
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20110913
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name HYDROCHLOROTHIAZIDE; LISINOPRIL
Strength Number 12.5; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient]

Complete Information of Lisinopril and Hydrochlorothiazide


General Information